✦ LIBER ✦

Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments

✍ Scribed by Philip Wintermeyer; Jack R. Wands

Book ID: 106180178
Publisher: Springer Japan
Year: 2007
Tongue: English
Weight: 202 KB
Volume: 42
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-007-2057-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B vaccination in patients with

Hepatitis B vaccination in patients with chronic liver disease secondary to hepatitis C virus infection (CLDC)

✍ Cristiane Both; Eliana Gomes; Claudio Alexandre; Jose Remiao; Gabriela Coral; An 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Immunoglobulin M and A antibodies to hep

Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection

✍ George K. K. Lau; Richard Lesniewski; Rhonda G. Johnson; Gary L. Davis; Johnson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## Abstract To determine the prevalence and clinical significance of IgM and IgA antibody to hepatitis C virus (HCV) core antigen in chronic HCV infection, sera from 47 patients were tested for immunoglobulin class M (IgM) and immunoglobulin A (IgA) antibody to HCV core antigen by solid‐phase enzym

O.102 Combination therapy with entecavir

O.102 Combination therapy with entecavir and “prime-boost” vaccines prevents the development of chronic duck hepatitis B virus infection

✍ D.S. Miller; D. Boyle; I. Kotlarski; R. Colonno; A.R. Jilbert 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Meeting vaccination quality measures for

Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection

✍ Jennifer R. Kramer; Christine Y. Hachem; Fasiha Kanwal; Minghua Mei; Hashem B. E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 1 views

Coinfection with hepatitis A virus (HAV) or hepatitis B virus (HBV) in patients with chronic hepatitis C virus (HCV) is associated with increased morbidity and mortality. The Center for Medicare and Medicaid Services has identified HAV and HBV vaccination as a priority area for quality measurement i

Estimating progression to cirrhosis in c

Estimating progression to cirrhosis in chronic hepatitis C virus infection

✍ Anthony J. Freeman; Gregory J. Dore; Matthew G. Law; Max Thorpe; Jan Von Overbec 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Susceptibility to hepatitis A in patient

Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination

✍ Michael Shim; Inessa Khaykis; James Park; Edmund J. Bini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. Although HAV vaccination is recommended for all patients with chronic hepatitis C virus (HCV) infection, little is known about adherence to these recomm